Alkermes
demonstrated dose dependent increases in exposure and wakefulness pharmacodynamics strong relationship demonstrated in rat model suggests potential for low human dose did not adversely elevate heart rate and blood pressure in a rat hemodynamic model at pharmacologically relevant plasma exposures alkermes data on file time time | Alkermes
Company
Deck Type
Deck date
March 2021
Slide
139 of 144
Related slides by other companies
Investor Presentation
March 2023
Investor Presentation
March 2023
Investor Presentation
March 2023
Investor Presentation
February 2023
Other recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io